Keay Nakae
Stock Analyst at Chardan Capital
(1.82)
# 3,438
Out of 5,126 analysts
597
Total ratings
36.1%
Success rate
0.1%
Average return
Main Sectors:
Stocks Rated by Keay Nakae
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $425 → $375 | $159.85 | +134.59% | 52 | Oct 30, 2026 | |
| SLN Silence Therapeutics | Downgraded: Hold | $20 | $19.77 | +1.16% | 20 | Oct 19, 2026 | |
| CAMP Camp4 Therapeutics | Reiterated: Buy | $6.5 → $6 | $4.20 | +42.86% | 2 | Sep 29, 2026 | |
| PRME Prime Medicine | Reiterated: Buy | $7 | $4.30 | +62.79% | 2 | Sep 24, 2026 | |
| EPA: ALSEN Sensorion SA | Reiterated: Buy | €50.00 | €8.28 | +503.86% | 3 | Sep 16, 2026 | |
| RCKT Rocket Pharmaceuticals | Reiterated: Buy | $11 | $2.48 | +343.55% | 2 | Sep 15, 2026 | |
| HIND Vyome Holdings | Initiated Coverage: Buy | $3.5 | $1.57 | +122.93% | 1 | Sep 3, 2026 | |
| PMN ProMIS Neurosciences | Reiterated: Buy | $20 → $33 | $3.76 | +777.66% | 2 | Aug 13, 2026 | |
| MGX Metagenomi Therapeutics | Reiterated: Buy | $5 | $0.7563 | +561.11% | 2 | Aug 10, 2026 | |
| BME: PHM Pharma Mar, S.A. | Reiterated: Buy | €100.00 | €69.30 | +44.30% | 9 | Aug 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $14.41 | +4.09% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $49.36 | +132.98% | 49 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $27.76 | +26.08% | 2 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $38 | $17.99 | +111.23% | 20 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €0.08 | €0.07 | +7.53% | 3 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.8242 | +506.65% | 7 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3 | $1.26 | +138.10% | 40 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $16 | $3.11 | +414.47% | 20 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $3.21 | +336.14% | 19 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $31.15 | -3.69% | 4 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ¥800 | ¥240 | +233.33% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $6.01 | +232.78% | 12 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2.5 → $45 | $0.002 | +2,249,900.00% | 6 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $0.34 | +11,664.71% | 1 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €10.00 → €5.00 | €0.62 | n/a | 5 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $85 | $71.73 | n/a | 2 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $25 → $6 | $1.50 | n/a | 19 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.66 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 4 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.49 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.03 | n/a | 20 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.5 → $5 | $3.88 | n/a | 47 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.11 | n/a | 7 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $8 | $1.50 | n/a | 14 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 13 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.65 | n/a | 16 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.20 | n/a | 1 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.04 | n/a | 31 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.98 | n/a | 5 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.69 | n/a | 1 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 → $50 | $0.0001 | n/a | 8 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.11 | n/a | 15 | Sep 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.19 | n/a | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.31 | n/a | 9 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 6 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2,550.00 | n/a | 9 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.11 | n/a | 15 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.20 | n/a | 8 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $4.5 | $0.9604 | n/a | 9 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.3294 | n/a | 2 | Nov 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $2 | $2.39 | n/a | 11 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $248.69 | n/a | 1 | Mar 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0002 | n/a | 2 | Jan 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.45 | n/a | 1 | Jun 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $31.25 | n/a | 3 | Jun 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.35 | n/a | 3 | Dec 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.19 | n/a | 1 | Aug 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.25 | $2.65 | n/a | 1 | Aug 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.25 → $2 | $0.0001 | n/a | 4 | Jul 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $6 | $1.11 | n/a | 4 | Mar 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $0.6514 | n/a | 1 | Dec 3, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $0.801 | n/a | 1 | Aug 6, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 → $18 | $0.0003 | n/a | 3 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $3.29 | n/a | 1 | Oct 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2.3 | $0.1609 | n/a | 1 | Jun 25, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $59.45 | n/a | 1 | May 16, 2012 |
Alnylam Pharmaceuticals
Oct 30, 2026
Reiterated: Buy
Price Target: $425 → $375
Current: $159.85
Upside: +134.59%
Silence Therapeutics
Oct 19, 2026
Downgraded: Hold
Price Target: $20
Current: $19.77
Upside: +1.16%
Camp4 Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $6.5 → $6
Current: $4.20
Upside: +42.86%
Prime Medicine
Sep 24, 2026
Reiterated: Buy
Price Target: $7
Current: $4.30
Upside: +62.79%
Sensorion SA
Sep 16, 2026
Reiterated: Buy
Price Target: €50.00
Current: €8.28
Upside: +503.86%
Rocket Pharmaceuticals
Sep 15, 2026
Reiterated: Buy
Price Target: $11
Current: $2.48
Upside: +343.55%
Vyome Holdings
Sep 3, 2026
Initiated Coverage: Buy
Price Target: $3.5
Current: $1.57
Upside: +122.93%
ProMIS Neurosciences
Aug 13, 2026
Reiterated: Buy
Price Target: $20 → $33
Current: $3.76
Upside: +777.66%
Metagenomi Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $5
Current: $0.7563
Upside: +561.11%
Pharma Mar, S.A.
Aug 9, 2026
Reiterated: Buy
Price Target: €100.00
Current: €69.30
Upside: +44.30%
Aug 6, 2026
Reiterated: Buy
Price Target: $15
Current: $14.41
Upside: +4.09%
Aug 4, 2026
Reiterated: Buy
Price Target: $115
Current: $49.36
Upside: +132.98%
Aug 3, 2026
Reiterated: Buy
Price Target: $35
Current: $27.76
Upside: +26.08%
Jul 29, 2026
Reiterated: Buy
Price Target: $40 → $38
Current: $17.99
Upside: +111.23%
Jul 15, 2026
Reiterated: Hold
Price Target: €0.08
Current: €0.07
Upside: +7.53%
Jul 1, 2026
Reiterated: Buy
Price Target: $5
Current: $0.8242
Upside: +506.65%
Jun 25, 2026
Reiterated: Buy
Price Target: $4 → $3
Current: $1.26
Upside: +138.10%
Jun 16, 2026
Reiterated: Buy
Price Target: $14 → $16
Current: $3.11
Upside: +414.47%
May 12, 2026
Reiterated: Buy
Price Target: $14
Current: $3.21
Upside: +336.14%
Apr 21, 2026
Reiterated: Buy
Price Target: $30
Current: $31.15
Upside: -3.69%
Apr 7, 2026
Initiated Coverage: Buy
Price Target: ¥800
Current: ¥240
Upside: +233.33%
Mar 12, 2026
Reiterated: Buy
Price Target: $20
Current: $6.01
Upside: +232.78%
Feb 24, 2026
Upgraded: Buy
Price Target: $2.5 → $45
Current: $0.002
Upside: +2,249,900.00%
Jan 5, 2026
Reiterated: Buy
Price Target: $40
Current: $0.34
Upside: +11,664.71%
Sep 30, 2025
Reiterated: Buy
Price Target: €10.00 → €5.00
Current: €0.62
Upside: n/a
Sep 25, 2025
Reiterated: Buy
Price Target: $60 → $85
Current: $71.73
Upside: n/a
May 8, 2025
Downgraded: Hold
Price Target: $25 → $6
Current: $1.50
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $7.66
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $1.49
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $1.03
Upside: n/a
Nov 19, 2024
Reiterated: Buy
Price Target: $4.5 → $5
Current: $3.88
Upside: n/a
Nov 18, 2024
Reiterated: Buy
Price Target: $6
Current: $1.11
Upside: n/a
Nov 12, 2024
Reiterated: Buy
Price Target: $10 → $8
Current: $1.50
Upside: n/a
Mar 14, 2024
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 12, 2023
Rated: Hold
Price Target: n/a
Current: $13.65
Upside: n/a
Mar 9, 2023
Reiterated: Buy
Price Target: n/a
Current: $9.20
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $6.04
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $9.98
Upside: n/a
Feb 6, 2023
Reiterated: Buy
Price Target: n/a
Current: $6.69
Upside: n/a
Nov 16, 2022
Downgraded: Hold
Price Target: $100 → $50
Current: $0.0001
Upside: n/a
Sep 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.11
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $13.19
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $9.31
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $2,550.00
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $1.11
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $1.20
Upside: n/a
Jun 10, 2021
Reiterated: Hold
Price Target: $8 → $4.5
Current: $0.9604
Upside: n/a
Nov 20, 2020
Rated: Hold
Price Target: n/a
Current: $0.3294
Upside: n/a
Jul 30, 2020
Rated: Hold
Price Target: $2
Current: $2.39
Upside: n/a
Mar 23, 2020
Reiterated: Buy
Price Target: n/a
Current: $248.69
Upside: n/a
Jan 28, 2020
Rated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
Jun 10, 2019
Rated: Hold
Price Target: n/a
Current: $7.45
Upside: n/a
Jun 10, 2019
Rated: Hold
Price Target: n/a
Current: $31.25
Upside: n/a
Dec 6, 2016
Reiterated: Buy
Price Target: $6
Current: $1.35
Upside: n/a
Aug 23, 2016
Reiterated: Buy
Price Target: $4
Current: $2.19
Upside: n/a
Aug 12, 2016
Reiterated: Buy
Price Target: $2.25
Current: $2.65
Upside: n/a
Jul 8, 2016
Reiterated: Buy
Price Target: $2.25 → $2
Current: $0.0001
Upside: n/a
Mar 28, 2016
Reiterated: Buy
Price Target: $12 → $6
Current: $1.11
Upside: n/a
Dec 3, 2014
Initiated Coverage: Buy
Price Target: $16
Current: $0.6514
Upside: n/a
Aug 6, 2014
Downgraded: Hold
Price Target: $4
Current: $0.801
Upside: n/a
May 15, 2014
Downgraded: Hold
Price Target: $100 → $18
Current: $0.0003
Upside: n/a
Oct 7, 2013
Initiated Coverage: Buy
Price Target: $13
Current: $3.29
Upside: n/a
Jun 25, 2013
Initiated Coverage: Buy
Price Target: $2.3
Current: $0.1609
Upside: n/a
May 16, 2012
Initiated Coverage: Buy
Price Target: n/a
Current: $59.45
Upside: n/a